urea has been researched along with AIDS, Simian in 12 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Excerpt | Relevance | Reference |
---|---|---|
" More MIV-150 was associated with cervical tissue 8 h after daily dosing of MIV-150/zinc acetate versus MIV-150, while comparable MIV-150 levels were associated with vaginal tissues and at 24 h." | 1.37 | An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. ( Abraham, CJ; Aravantinou, M; Blanchard, J; Chudolij, A; Fernández-Romero, JA; Gettie, A; Hsu, M; Kenney, J; Kizima, L; Lifson, JD; Menon, R; Piatak, M; Robbiani, M; Rodriguez, A; Seidor, S; Singer, R; Zydowsky, TM, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Derby, N | 7 |
Aravantinou, M | 7 |
Kenney, J | 7 |
Ugaonkar, SR | 1 |
Wesenberg, A | 1 |
Wilk, J | 1 |
Kizima, L | 9 |
Rodriguez, A | 9 |
Zhang, S | 4 |
Mizenina, O | 3 |
Levendosky, K | 3 |
Cooney, ML | 5 |
Seidor, S | 10 |
Gettie, A | 11 |
Grasperge, B | 2 |
Blanchard, J | 11 |
Piatak, M | 8 |
Lifson, JD | 9 |
Fernández-Romero, J | 1 |
Zydowsky, TM | 12 |
Robbiani, M | 11 |
Hsu, M | 2 |
Keele, BF | 1 |
Krawczyk, N | 1 |
Abraham, CJ | 4 |
Jean-Pierre, N | 4 |
Piatak, MJ | 1 |
Fernández-Romero, JA | 11 |
Ouattara, LA | 1 |
Barnable, P | 4 |
Mawson, P | 3 |
Roberts, KD | 2 |
Teleshova, N | 6 |
Menon, R | 7 |
Pugach, P | 1 |
Villegas, G | 2 |
Ford, BE | 1 |
Paglini, G | 1 |
Calenda, G | 3 |
Ouattara, L | 1 |
Abraham, C | 1 |
Sperling, R | 1 |
Bonnaire, T | 1 |
Clark, MR | 1 |
Doncel, GF | 1 |
Singer, R | 5 |
Chudolij, A | 2 |
Goldman, D | 2 |
12 other studies available for urea and AIDS, Simian
Article | Year |
---|---|
An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
Topics: Alphapapillomavirus; Animals; Antiviral Agents; Carrageenan; Contraceptive Agents, Female; Contracep | 2017 |
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents, Local; Drug Resistance, Viral; Female; | 2014 |
MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection.
Topics: Administration, Intravaginal; Animals; Female; Macaca; Pyridines; Reverse Transcriptase Inhibitors; | 2014 |
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV.
Topics: Alphapapillomavirus; Anal Canal; Animals; Anti-Infective Agents; Caco-2 Cells; Carrageenan; Female; | 2014 |
A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Carrageenan; Chemistry, Pharmaceutical; Fema | 2014 |
MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.
Topics: Administration, Intravaginal; Animals; Antiviral Agents; Cervix Uteri; Female; HIV Reverse Transcrip | 2015 |
Multipurpose Prevention Approaches with Antiretroviral-Based Formulations.
Topics: Administration, Intravaginal; Animals; Anti-Retroviral Agents; Carrageenan; Drug Combinations; Femal | 2016 |
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.
Topics: Administration, Intravaginal; Animals; Anti-Retroviral Agents; Drug Combinations; Female; Gels; HIV | 2011 |
The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.
Topics: Administration, Rectal; Animals; Anti-Infective Agents, Local; B-Lymphocytes; Carrageenan; Gels; Mac | 2011 |
A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.
Topics: Administration, Intravaginal; Administration, Rectal; Animals; Anti-Infective Agents; Female; Herpes | 2012 |
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection.
Topics: Administration, Intravaginal; Administration, Rectal; Animals; Carrageenan; Enzyme Inhibitors; Femal | 2012 |
An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques.
Topics: Administration, Intravaginal; Animals; Contraceptive Devices, Female; Female; Inhibitory Concentrati | 2012 |